Materials and Methods
Animals. C57BL/6J F1 nu/nu mice, 6-8 wk of age, and Lewis strain rats, 4 wk of age, were obtained from the Institut f/fir Biologisch-Medizinische Forschung A.G., F/illinsdorf, Switzerland.
Cell Cultures. Mouse spleen cells were prepared as described previously (2, 3) and cultured in a modified Dulbecco's-modified Eagle's medium containing albumin, transferrin, and which contained soybean lipid (12) (instead of fetal calf serum), 2-mercaptoethanol (5 X 10 -5 M), and kanamycin (Gibco Bio-Cult, Irvine, Scotland). Mass cultures were initiated at 3 × 105 cells/ml. Cultures at limiting dilutions of reactive B cells contained 3 X 106 rat thymus cells/ ml as growth-supporting filler cells (2) . Separation of cells of different size was done by velocity sedimentation using a gradient of 2-4% bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.) in balanced salt solution (BSS) (11) . After separation cell fractions were washed with BSS and then either recultured in mass cultures at 1-3 × 10 ~ cells/ml or in limiting dilutions in 3 × 106 rat filler cells/ml (Results). To minimize contaminations of medium-and large-size cells in the small cells fractions, cells in the ascending part of the peak of small cells, near the peak
the even smaller erythrocytes (11) , were taken. In a typxcal separatxon experiment, 10 cells of a selected fraction of small cells incorporated < 15 cpm [3H]thymidine (2 Ci/mMol, 10 #Ci/ ml) in 1 h into acid-precipitable material, and contained 100-600 background IgM-PFC. Mitogens. The smooth form of LPS from Salmonella abortus-equi was kindly prepared for us by Dr. C. Galanos and Dr. O. Liideritz, Max Planck Institut ffir Immunbiologie, Freiburg, West Germany. It was routinely used at 50 #g/ml in cultures. Both small, resting B cells as well as Bcell blasts showed their optimum activation at this concentration. Several batches of PPD tuberculin (Results) were obtained from Statens Serum Institute, Copenhagen, Denmark. Unless specified in the Results, they were routinely used at 100/~g/ml in cultures.
Assays. Cell concentrations in culture were determined with a Biirker hemocytometer.
Cultures were assayed for the number of cells secreting either IgM or IgG1 and IgG2 by the protein A-sheep erytbrocyte (SRC) plaque assay (13) . Protein A was prepared for us by Dr. H. Wigzell, Biomedicum, University of Uppsala, Uppsala, Sweden, or commercially obtained from Pharmacia AB, Uppsala, Sweden. Antibodies against purified MOPC 104E 19S IgM 0~, /L) against MOPC21 IgG (','1, J¢), and against PC-5 IgGz (Y2, to) were raised in rabbits by repeated injections of 0.5-1 mg of the myeloma protein in incomplete Freund's adjuvants and titrated for their optimal developing capacity in the plaque assay with myeloma protein-secreting myeloma cell lines and with LPS-stimulated spleen cells. Complement was from Gibco BioCult. Plaque assays specific for trinitrophenyl-substituted SRC (TNP30-SRC), horse ecythrocytes (HRC), or SRC were done as described previously (5) and detected IgM-secreting, direct, specific PFC.
Results

Growth Induction of Small, Resting B Cells by PPD Tuberculin and by LPS. Spleen cells
of C57BL/6J nu/nu mice were separated by velocity sedimentation (11, 14) into small, resting cells and into medium-and large-size cells (Materials and Methods). The separated small cells were thereafter cultured in the absence or presence of PPD tuberculin or LPS in a modified Dulbecco's medium containing the serum substitutes transferrin, serum albumin, and lipids (12) to increase survival of lymphocytes in culture and to exclude possible mitogens contained in serum. For 5 d thereafter, cells were counted in a hemocytometer. Small-and large-size cells were distinguished. Fig. 1 c shows that in the absence of added mitogen, the cells remained small, and the cell concentration remained practically constant over the 5-d period. In the presence of LPS (Fig. 1 a) , the number of small cells dropped within a day by onethird, then remained practically constant for the next 4 d. The drop in the number of In the presence of PPD tuberculin, a drop in the number of small cells within the first 24 h of stimulation similar to that observed with LPS could be seen (Fig. 1 b) . However, the total number of cells remained ,nstant and did not increase over the 5-d period. Approximately the same number o5 blast cells appeared within 24 h of stimulation as it had been observed in the LPS-stimulated cell cultures. These PPD tuberculin-induced blasts, however, apparently did not grow because their number remained practically constant for the next 4 d. The size of these blasts increased with time of stimulation.
PPD tuberculin-induced B-cell blasts also did not incorporate significant amounts of [3H]thymidine into DNA, very much like the unstimulated cell population, and in contrast to LPS-induced [3H]thymidine uptake in such stimulated cells (Table I) .
We conclude that PPD tuberculin induces blast transformation in a part, approximately one-third to one-fourth, of all small, resting splenic lymphocytes of C57BL/ 6J nu/nu mice, but does not initiate growth of these cells.
Induction of Small, Resting B Cells to Ig Secretion by PPD Tuberculin and by LPS. Separated, small, resting spleen cells of C57BL/6J nu/nu mice were induced, as expected, by LPS to the development of IgM-PFC in numbers comparable to those observed in previous experiments (12) (Fig. 2) . Approximately 10% of all blast cells The medium-and large-size cells in these cultures, purified by velocity sedimentation, were the Ig-secreting cells (data not shown). 5-10% of them actually produced a plaque (for this problem, see above), and the repertoire of these secreting cells was found to be polyclonal. Thus, 1 in 2 × 10 a PPD tuberculin-induced IgM-PFC were SRC specific, 1 in 450 HRC specific, and 1 in 100 TNPs0-SRC specific; very much like the repertoire of LPS-induced IgM-PFC obtained after growth and maturation and as published previously (5) . Of all blast cells in these cultures (Fig. 1 b) ~5-10% could be detected as IgM-PFC.
PPD We conclude that PPD tuberculin, although not stimulating growth of small, resting B cells, induces polyclonal maturation to blast-like, large IgM-and IgGsecreting cells.
Growth Stimulation of Activated B-Cell Blasts by PPD Tuberculin and by LPS.
Activated B-cell blasts can be generated from resting B cells of spleen in a 48-h incubation period with B-cell mitogens such as LPS (9) . They can be separated from nonactivated small cells by velocity sedimentation. Such LPS-activated B-cell blast populations contain >98% Ig+ cells and are, therefore, highly enriched. Another source of activated B-cell blasts are the medium-and large-size cells of spleen, which are, however, contaminated by large cells of other origins, such as macrophages etc. Both types of B-cell blasts need the presence of the growth-stimulating mitogens early after division in the cell cycle to go through the next round of division. This requirement in each cell cycle of a growing clone of B cells has been used previously to assay given B-cell blast populations for their reactivities toward several different B-cell mitogens (9) . The same experimental principle of restimulation of growth and maturation is used here to study the growth-and maturation-stimulating properties of PPD tuberculin with LPS-activated and with background-activated B-cell blasts.
LPS-activated B-cell blasts were cultured in the absence or presence of LPS (the homologous mitogen) as controls, or in the presence of PPD tuberculin. Growth and induction to IgM-PFC was measured (Fig. 3) .
The numbers of growing cells and the numbers of IgM-PFC induced by PPD tuberculin compared to the homologous mitogen LPS show that approximately onehalf of the LPS-induced B-cell blasts can continue to grow and to mature to IgM secretion in the presence of the heterologous B-cell mitogen PPD tuberculin. Two conclusions can be reached from these results: (a) B-cell blasts generated by LPSactivation of resting C57BL/6J nu/nu spleen cells (6-8 wk old) contain more than one mitogen reactivity for, and therefore probably more than one receptor for LPS and for PPD tuberculin and (b) PPD tuberculin, although unable to activate and stimulate resting B cells to growth, is able to stimulate activated B-cell blasts to growth and secretion.
Medium-and large-size cells, enriched from spleen cells by velocity sedimentation, were also tested for their susceptibility to stimulation by PPD tuberculin. There was a minor increase in the total number of cells in culture, as a result of the fact that the 18  3  10  15  3  10  1  15  10  20  30  10  35  2  30  30  150  120  25  100  5  100  100  400  350  65  420  l0  310  300  400  400  55  300  10  300  1,000  80  95  15  70  3 Results in Table III show that different batches of PPD tuberculin have different properties. One batch activates resting B cells to growth almost as well as LPSactivated B-cell blasts, a second has a reduced, but measurable activating influence on resting cells, whereas a third, which was used throughout the studies reported in this paper (above), has no measurable activating capacity for resting cells. As seen from the data, this is so at concentrations of PPD tuberculin between 1 mg/ml and 1 /~g/ml. All batches activate LPS-induced B-cell blasts equally well. The optimal stimulatory capacity for B-blasts is between 100 and 300/~g/ml PPD tuberculin.
It is evident that some PPD tuberculin batches will have to be purified to separate mitogens that stimulate resting, as well as activated cells from mitogens that stimulate only activated cells. Earlier experiments, performed under conditions where there were very limited possibilities for murine B lymphocytes to grow and to mature to Ig secretion (18), identified PPD tuberculin as a B-cell mitogen which appeared to activate B-cell subpopulations characterized as late in their development to Ig-secreting cells (19, 20) . Somewhat in contrast to these results, it was found in other experiments, that LPS and PPD tuberculin activated largely the same B-cell populations, indicating that B cells could be reactive to more than one mitogen (20, 21) . Our results presented in this paper, i.e., that LPS can stimulate resting B cells as well as activated B-cell blasts, whereas PPD tuberculin can only stimulate activated B-cell blasts, but not resting B cells, force us to reinterpret these earlier results. It appears now most likely that already activated, background B-cell blasts of spleen have been further stimulated under these earlier, more limited conditions of in vitro cultures. This action of PPD tuberculin on B cells would certainly support the previous interpretation that PPD stimulated late B cells (20, 22) , if one accepts an activated B-cell blast on its way to becoming a mature plasma cells as a distinct stage of B-cell development.
Alternately, it is possible that part of the earlier discrepancies in experimental results were a result of the different mitogenic action of different batches of PPD tuberculin (see Table III ). It is also not excluded that at the cell concentrations (i.e., 5 × 106 cell/ml) used in the earlier experiments, interactions of other cells with the resting B cells may render the resting B cells activated, and consequently susceptible, to stimulation by PPD tuberculin. This latter possibility will have to be probed experimentally with more-carefully purified, resting B-cell populations.
Our studies on the action of PPD tuberculin on B cells have certainly been inspired by studies on T-cell activation (23, 24) . In these studies, it was shown that resting, small T-cells, carefully purified from B cells, activated large cells and macrophages could not be stimulated by mitogens (factors) contained in supernates ofconcanavalin A-treated spleen cells (23) unless these resting cells had previously been treated with antigen or with concanavalin A. Antigen, in this case allogeneic cells, or concanavalin A alone, on the other hand, did not stimulate the resting T cells to growth. Our results with B cells and their activation by PPD tuberculin point to a striking similarity in the distinction of a resting, from an activated, state of a lymphocyte and may suggest a similar mode of activation of T and B cells by antigens plus mitogens.
We have, on occasions, observed similar stimulatory effects with selected batches of fetal calfsera and transferrin preparations on activated B-cell blasts, whereas the same batches were nonstimulatory for resting cells. This appears of importance wherever Bcell activation by cooperative factors and by anti-Ig antibodies is studied in the presence of fetal calf serum (25, 26) . In particular, exPerimental conditions should be critically assessed for the presence of PPD tuberculin-like mitogens, whenever the action of anti-Ig antibodies on B cells leads to stimulation.
T-cell dependent help in the antigen-specific activation and stimulation of resting B cells is another likely candidate for such a PPD tuberculin-like mitogen for B cells, whether the mitogen itself is directly supplied by T cells, or indirectly via the activation of mitogen-producing third cells such as macrophages. Such action of Tcell help may be in effect where in vitro differentiation of human leukemic B lymphocytes to Ig-secreting plasma ceils has been observed (27) .
The cell cycle of growing eukaryotic cells is characterized by two events which are separated in time: ceil division (mitosis [M] ) and DNA-synthesis (S-phase). The gap after M and preceding S-phase is called Ga, the gap after S-phase and preceding M is called G2. Activated, growing B cells need the action ofa mitogen (such as LPS etc., 9) after M early in G1 to proceed through the next cell cycle and to complete M (W. Lernhardt and F. Melchers. Manuscript in preparation.). PPD tuberculin, as much as the commonly known B-cell mitogens LPS or LP (6, 7) , is able to convey this type of mitogenesis to B cells. PPD tuberculin is, therefore, not deficient in its ability to stimulate growth. Because PPD tuberculin is able to do so with a large number (approximately one-half) of all LPS-activated B-cell blasts, we have to conclude in close similarity to conclusions previously reached for LPS-, LP-, and NOC-reactive B cells (9) , that a majority (~50%) of all splenic B cells (of a C57BL/6J nu/nu mouse, 6-8 wk of age) are reactive to more than one mitogen, now including PPD tuberculin, and, therefore, probably possess more than one mitogen receptor. It should be recalled here that a direct action of these B-cell mitogens on B cells, under circumvention of help from T cells or adherent cells, is concluded from the finding that growth of single clones of B cells in semi-solid media is dependent on the presence of such B-cell mitogens (28, 29) .
Resting cells do not synthesize DNA and do not divide. Their resting state has been called the G0-phase of the cell cycle. Activation of resting cells, i.e., of resting B cells by LPS, results in an activation of DNA-synthesis followed by M. From the G0-phase cells, therefore, B cells first enter the S-phase and then G2-phase and M of the cell cycle. Thereafter, they proceed through Ga, S-phase, Gz, and M and so on, as long as the stimulatory mitogen is present (above). The results of this paper establish for B cells that G0-phase B cells require, in part, different, and probably more, signals to become activated and stimulated to growth than do activated B cells to enter the next cell cycle. Mitogens, such as PPD tuberculin, which do not activate resting G0-phase B lymphocytes, but which will stimulate activated Gl-phase B-cell blasts, pose the intriguing problem as to what renders a resting G0-phase B cell susceptible to stimulation by such Gl-phase-only mitogens.
The most likely reaction which could render a resting G0-phase B cell susceptible to stimulation by Gl-phase-only mitogens is the binding of antigen to surface Ig molecules. This may induce changes in the surface membrane which may expose a functionally hidden receptor for the mitogen. G0-Gl-phase mitogens, such as LPS, LP, NOC, and mitogens in fetal calf serum, as a result of their lipophilic nature, may induce such changes in G0-phase B cells, by their very ability to insert themselves into the lipid bilayer of the B-cell surface membrane, which, of course, also contains the mitogen-specific receptors. Such a difference in action of G0-Gl-phase and Ga-phaseonly mitogens may, in fact, offer an explanation for the observed difference in activating potential between T-independent antigens of type 1 (hapten on LPS, LP, NOC, and Brucella abortus) and such of type 2 (pneumococcal polysaccharide, dextran, and levan).
Finally, it appears still feasible to expect (30, 31) that recognitions by the B cells additional to the binding of antigen to surface Ig molecules, as i.e., of H-2-encoded molecules, may be required to change a G0-phase B cell to its activated form susceptible for Gl-phase-only mitogens. Received for publication l l June 1979.
